BioengineeringbioRxivPreprint
An engineered IdeS variant with enhanced activity and performance for IgG degradation
Keyi Zhang, Wenhao Ma, Zhijie Wu…·XC Wu
This paper engineers an improved IgG-degrading enzyme, IdeSM33, showing enhanced activity and IgG depletion in vivo, with therapeutic potential for autoimmune diseases and gene therapy.